Revenue: Reached $3.05 billion, up 22% year-over-year and ahead of the expected $2.91 billion.
EPS of $3.00 per share.
Repurchased 7.8 million shares ($2.94 billion) during the quarter; cash and investments stood at approximately $6.8 billion.
Worldwide procedures (da Vinci and Ion combined) grew approximately 15% compared with the third quarter of 2025. Da Vinci procedures grew approximately 14%, and Ion procedures grew approximately 31%.
Sales of $25.0 billion, up 11 percent versus prior year, and up 12 percent organically*
GAAP EPS of $1.89, including $0.26 of acquisition accounting adjustments and $0.11 of restructuring and other net significant and/or non-recurring items
Adjusted EPS* of $2.26, up $0.56, or 33 percent, versus prior year, including $0.25 from IEEPA cost recovery
Operating cash flow of $2.9 billion, including approximately $0.3 billion from IEEPA recovery; free cash flow* of $2.1 billion
Company backlog of $340 billion, including $176 billion of commercial and $164 billion of defense
Awarded Tomahawk and AMRAAM multi-year undefinitized production contracts in the third quarter
Updates outlook for full year 2026
Adjusted sales* of $97.0 – $97.5 billion, up from $95.0 – $96.0 billion
Organic sales growth* of 10 to 11 percent, up from 8 to 9 percent
Adjusted EPS* of $7.65 – $7.75, up from $7.10 – $7.25
Free cash flow* of $9.0 – $9.2 billion, up from $8.50 – $8.75 billion
Q3 is expected to show 37% sequential and 336% annual revenue growth, with analysts projecting $6.25 adjusted EPS on $74.6B revenue.
Outlook:
Q3 should deliver around $6.25 EPS, on around $75B in revenue, annual growth of 336%, up from around $17.1B. .
1. Upcoming Earnings Date
Next Earnings Release:October 28, 2026 (9:00 AM KST) / October 27, 2026 (US ET).
Period: FY2026 Third Quarter (Q3).
2. Expected Revenue & Growth
Consensus Q3 Revenue Forecast:
~₩99.7 Trillion – ₩100.6 Trillion KRW (equivalent to approximately $74.6 Billion USD).
Expected Revenue Growth:
Year-over-Year (YoY):~+300% to +330% (up from ₩24.45 Trillion KRW in Q3 2025).
Quarter-over-Quarter (QoQ):~+26% to +27% sequential expansion over Q2 2026 (₩79.32T KRW).
3. Expected Profit / Earnings Growth
Consensus Q3 EPS Estimate:
~$6.12 – $6.25 USD per ADR (analyst consensus ranges).
Expected Profit Growth:
Year-over-Year (YoY):~+370% to +390% YoY (compared to $1.25 EPS reported in Q3 2025).
Profitability continues to be propelled by strong demand and pricing power across high-bandwidth memory (HBM3E / HBM4) and enterprise server DRAM/NAND.
